Plasma kisspeptin levels in lactational amenorrhea.
Kotani. Masato M; Katagiri. Fumihiko F; Hirai. Tsuyoshi T; Kagawa. Jiro J; Tanaka. Issei I
Key Findings
- Plasma kisspeptin in lactational amenorrhea (15.2 ± 2.5 fmol/mL) was similar to that in age‑matched women with regular cycles (16.5 ± 4.8 fmol/mL).
- Women with various pathological amenorrhea showed lower and more variable kisspeptin levels (5.8–13.7 fmol/mL).
- The data imply that circulating kisspeptin may have a different physiological role than brain‑localized kisspeptin in regulating reproductive hormones.
Practical Outcomes
- For most biohackers focused on longevity, metabolism, or performance, this study offers little direct guidance. It suggests that simply measuring or trying to modify blood kisspeptin levels is unlikely to impact menstrual suppression during breastfeeding or general reproductive health in a predictable way. No actionable dosing or protocol recommendations emerge from these findings.
Summary
The study measured the amount of the hormone‑like peptide kisspeptin in the blood of women who were not having periods because they were breastfeeding (lactational amenorrhea) and compared it to women with normal cycles and a few women with other types of amenorrhea. Kisspeptin levels were about the same in breastfeeding women as in normal‑cycle women, and varied in the pathological cases, suggesting that circulating kisspeptin isn’t dramatically lowered during lactational or some pathological amenorrhea.
Abstract
The kisspeptin is a neuropeptide to play physiological roles in regulating gonadotropin-releasing hormone secretion in the hypothalamus. In human plasma, the kisspeptin concentration is measured, but gonadotropin-releasing hormone is not. This study aims to understand the physiological roles of the circulating kisspeptin in lactational amenorrhea in humans because prolactin reduces the kisspeptin expression and luteinizing hormone secretion resulting in anovulations in rodent brains. Plasma kisspeptin levels were measured in 11 subjects in lactational amenorrhea and in four cases with pathological amenorrhea by different etiologies for comparison using the enzyme immunoassay specific for human kisspeptin. The plasma kisspeptin levels in the 11 women with lactational amenorrhea were 15.2 ± 2.5 fmol/mL (mean ± SD) which were not significantly different as compared with 16.5 ± 4.8 fmol/mL (mean ± SD) in four age-matched women with menstrual cycles as we reported previously. In the four cases with pathological amenorrhea, their plasma kisspeptin levels were from 5.8 to 13.7 fmol/mL. This study demonstrated that the plasma kisspeptin levels were not totally reduced in lactational or pathological amenorrhea. These results suggest the physiological roles of the circulating kisspeptin are different from the role in the brain.
Study Information
pubmed
2017
2017-05-11T00:00:00.000Z
10.1080/09513590.2017.1320380
6
20